Treating at the Earliest Sign of MS May Offer Long-Term Benefit
American Academy of Neurology (AAN)MINNEAPOLIS – Starting medication for multiple sclerosis (MS) in people who show the beginning signs of the disease is associated with prolonging the time before the disease is definitively diagnosed, according to a long-term study published in the August 10, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.